Annotation Detail for NCR3

Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa04650 | Natural killer cell mediated cytotoxicity |
Desease ID | Desease Name |
---|
1707 | Multiple myeloma |
1781 | Rheumatoid arthritis |
1882 | Malaria |
Desease Name |
---|
weight |
METABOLIC |
Desease Name |
---|
Malaria, mild, susceptibility to |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of NCR3 mRNA | affects expression | 16483693
|
D004786 |
Toxic Actions |
Toxic Actions results in decreased expression of NCR3 protein | decreases expression | 18468695
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of NCR3 protein | decreases expression | 17107666
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.30 | 18287403 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.98 | 15955085 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.32 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.34 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.44 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.99 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
4.09 | 16197459 16206674 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.23 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
5.33 | 16813970 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
6.03 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
1.92 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.38 | 16051514 16096774 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.32 | 17460283 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
5.33 | 16129372 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
6.03 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.81 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
4.35 | 17035595 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.83 | 17551590 9125849 16925845 9664655 10589399 14991402 9142499 9224671 8800419 9211117 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
5.33 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.37 | 16569247 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.90 | 16938888 9664655 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
4.16 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.27 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.46 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
6.03 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
3.09 | 9664655 14991402 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.57 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
5.22 | 16778211 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.42 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.39 | 17551590 15992940 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.95 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
4.18 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.13 | 19850784 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.42 | 16140955 12679006 17301526 17339181 17368321 17361223 19035177 16823087 16935935 17294898 19225113 19075265 16766008 19642359 15748426 17649720 16331271 16788101 19029980 17712046 17217047 17107899 9834237 17506722 16891316 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.62 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
1.81 | 16248980 18397230 |
OMIM:609148 |
MALARIA, MILD, SUSCEPTIBILITY TO |
marker/mechanism |
|
| |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.92 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.99 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
5.08 | 16940565 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.30 | 17596541 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.59 | 16594593 16946489 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
4.36 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.32 | 9142499 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.45 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.28 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.58 | 15976015 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
4.13 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.54 | 16723453 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.63 | 16116481 16283617 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
2.78 | 16467112 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.36 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
4.24 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.47 | 16040207 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
4.12 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
5.48 | 16752155 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.64 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.39 | 16287080 |
Pathway ID |
Pathway Name |
---|
KEGG:04650 |
Natural killer cell mediated cytotoxicity |